Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1960 1
1963 1
1964 2
1968 2
1969 1
1970 3
1971 5
1972 5
1973 3
1974 1
1975 2
1976 2
1977 2
1978 3
1979 4
1980 4
1981 2
1982 3
1983 4
1985 1
1986 5
1988 3
1989 3
1990 2
1991 7
1992 6
1993 3
1994 5
1995 3
1996 7
1997 4
1998 7
1999 6
2000 4
2001 6
2002 2
2003 4
2004 8
2005 8
2006 3
2007 8
2008 3
2009 10
2010 10
2011 9
2012 14
2013 11
2014 16
2015 13
2016 11
2017 14
2018 17
2019 13
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

286 results
Results by year
Filters applied: . Clear all
Page 1
Tuberculosis, hepatitis B and herpes zoster in tofacitinib-treated patients with rheumatoid arthritis.
Zhang Z, Deng W, Wu Q, Sun L. Zhang Z, et al. Immunotherapy. 2019 Mar;11(4):321-333. doi: 10.2217/imt-2018-0113. Epub 2019 Jan 11. Immunotherapy. 2019. PMID: 30630365 Review.
Tofacitinib has been studied extensively in patients with rheumatoid arthritis and has been shown to be effective and generally safe. ...
Tofacitinib has been studied extensively in patients with rheumatoid arthritis and has been shown to be effective and generally safe. …
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial.
Burmester GR, Kremer JM, Van den Bosch F, Kivitz A, Bessette L, Li Y, Zhou Y, Othman AA, Pangan AL, Camp HS. Burmester GR, et al. Lancet. 2018 Jun 23;391(10139):2503-2512. doi: 10.1016/S0140-6736(18)31115-2. Epub 2018 Jun 18. Lancet. 2018. PMID: 29908669 Clinical Trial.
BACKGROUND: Upadacitinib is a selective inhibitor of Janus kinase 1 and was efficacious in phase 2 studies in patients with moderate-to-severe rheumatoid arthritis. ...We enrolled patients aged 18 years or older with active rheumatoid arthritis for 3 months o …
BACKGROUND: Upadacitinib is a selective inhibitor of Janus kinase 1 and was efficacious in phase 2 studies in patients with moderate-to-seve …
Varicella arthritis in childhood: a case report and review of the literature.
Bevilacqua S, Poircuitte JM, Boyer L, May T, Lascombes P, Venard V. Bevilacqua S, et al. Pediatr Infect Dis J. 2011 Nov;30(11):980-2. doi: 10.1097/INF.0b013e318223c0d8. Pediatr Infect Dis J. 2011. PMID: 21633319 Review.
Nonbacterial arthritis is a rare but well-recognized complication of acute varicella in children. Reported cases usually described monoarthritis of the knee that occurs at the onset of the rash or shortly after. ...A review of the literature reported 26 previous cas …
Nonbacterial arthritis is a rare but well-recognized complication of acute varicella in children. Reported cases usually descr …
Varicella-associated arthritis occurring before the exanthem. Case report and literature review.
Fierman AH. Fierman AH. Clin Pediatr (Phila). 1990 Mar;29(3):188-90. doi: 10.1177/000992289002900311. Clin Pediatr (Phila). 1990. PMID: 2407411 Review.
Varicella-associated arthritis represents an uncommon complication of varicella in children. In 20 previously reported cases, three were documented to be bacterial in origin. Viral isolation from synovial fluid was attempted in seven others, and varicella
Varicella-associated arthritis represents an uncommon complication of varicella in children. In 20 previously reported
Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
Speth F, Hinze CH, Andel S, Mertens T, Haas JP. Speth F, et al. Pediatr Rheumatol Online J. 2018 Mar 2;16(1):15. doi: 10.1186/s12969-018-0231-3. Pediatr Rheumatol Online J. 2018. PMID: 29499726 Free PMC article. Clinical Trial.
BACKGROUND: The goal of this study was to apply the varicella zoster virus (VZV) vaccine to patients with pediatric rheumatic diseases (PRD) at risk for severe chickenpox, without interrupting their current immunosuppression, including biological agents, using an im …
BACKGROUND: The goal of this study was to apply the varicella zoster virus (VZV) vaccine to patients with pediatric rheumatic disease …
Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis.
Krasselt M, Baerwald C, Liebert UG, Seifert O. Krasselt M, et al. Clin Rheumatol. 2019 Sep;38(9):2493-2500. doi: 10.1007/s10067-019-04563-9. Epub 2019 Apr 26. Clin Rheumatol. 2019. PMID: 31028550
The incidence in patients with rheumatoid arthritis (RA) is at least twice as high as in healthy people. Nevertheless, little is known about humoral immunity against varicella zoster virus (VZV), in particular in patients with RA. ...KEY POINTS: • Humoral immunity t …
The incidence in patients with rheumatoid arthritis (RA) is at least twice as high as in healthy people. Nevertheless, little is know …
Varicella-Zoster virus hip arthritis in a rheumatoid arthritis patient.
Senlis M, Ottaviani S, Gardette A, Palazzo E, Coustet B, Dieudé P. Senlis M, et al. Joint Bone Spine. 2017 Mar;84(2):241-242. doi: 10.1016/j.jbspin.2016.02.030. Epub 2016 Jun 3. Joint Bone Spine. 2017. PMID: 27269653 No abstract available.
A case report of severe recurrent varicella in an ankylosing spondylitis patient treated with adalimumab - a new side effect after 15 years of usage.
Skuhala T, Atelj A, Prepolec J, Al-Mufleh M, Stanimirović A, Vukelić D. Skuhala T, et al. BMC Infect Dis. 2019 Feb 7;19(1):127. doi: 10.1186/s12879-019-3768-y. BMC Infect Dis. 2019. PMID: 30732563 Free PMC article.
BACKGROUND: Tumor necrosis factor-α (TNF-α) antagonists, most of which are monoclonal antibodies, became a widespread treatment for autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel diseases, psoriasis, psoriatic arthritis, …
BACKGROUND: Tumor necrosis factor-α (TNF-α) antagonists, most of which are monoclonal antibodies, became a widespread treatment for autoimmu …
Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era.
Cacciapaglia F, Zuccaro C, Iannone F. Cacciapaglia F, et al. Clin Exp Rheumatol. 2015 Nov-Dec;33(6):917-23. Epub 2015 Sep 22. Clin Exp Rheumatol. 2015. PMID: 26394271 Review.
Patients with rheumatoid arthritis are increasingly being treated with different drugs (both non-biologic and biologic disease-modifying anti-rheumatic drugs - DMARDs) that may have immunomodulatory, cytotoxic, or immunosuppressive effects; in particular, anti-tumour necro …
Patients with rheumatoid arthritis are increasingly being treated with different drugs (both non-biologic and biologic disease-modify …
286 results
Jump to page
Feedback